Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
ABBOTT MEDICAL BELGIUM from Zaventem, company number BE0441665942, closed financial year 2025 with a result of € 33,849 after tax. For that financial year ABBOTT MEDICAL BELGIUM recorded revenue of € 85.5 million and equity of € 13.3 million. Compared with financial year 2024, the result moved from € 3.7 million to € 33,849. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ 13.3 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,849
▼ 99% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 7.3 million.
People and assets in 2025
75.4
▼ 2.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 14.3 million
▲ 16% vs 2024
€ 189,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 11.5 million
▲ 10% vs 2024
Loans from banks and other lenders, long and short.
€ 8.9 million
▲ 242% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 48 days on average.
€ 4.7 million
▲ 73% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 72,326,126 | € 77,054,489 | € 78,012,590 | € 85,496,872 | ▲ 10% |
| Profit after taxes | € 1,073,343 | € 1,389,982 | € 3,706,038 | € 33,849 | ▼ 99% |
| Equity | € 15,617,576 | € 9,433,977 | € 13,280,011 | € 13,313,860 | |
| Total debts | € 14,437,300 | € 19,823,335 | € 17,708,993 | € 27,509,069 | ▲ 55% |
| Cash | - | € 3,781 | - | - | |
| Retained profit | € 9,589,515 | € 3,405,916 | € 7,251,950 | € 7,285,799 | |
| Bank debt | € 2,620,081 | € 8,573,158 | € 10,490,472 | € 11,546,114 | ▲ 10% |
| Balance sheet total | € 30,054,875 | € 29,257,312 | € 30,989,004 | € 40,822,929 | ▲ 32% |
| Employees (FTE) | 85 | 78.8 | 77.9 | 75.4 | ▼ 2.5 |
Key figures of ABBOTT MEDICAL BELGIUM, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ABBOTT MEDICAL BELGIUM?
What happened at ABBOTT MEDICAL BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Tim Demaerschalk stepped down as director. NBB
- Bradley Jay Slater stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 33,849 (▼ 99% vs 2024). Source: NBB ↗
- Tim Demaerschalk became a director. NBB
- Bradley Jay Slater became a director. NBB
- New establishment in Machelen (Brab.). KBO
- New establishment in Zaventem. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.1 million profit in 2021 to € 33,849 profit in 2025.
Paid € 3.7 million in corporate taxes since 2021.
Best year ever: 2024, with € 3.7 million profit.
Pays suppliers within 48 days on average.
A new publication or filing at ABBOTT MEDICAL BELGIUM? We notify you, reason included.
Follow ABBOTT MEDICAL BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Abbott SA (100%) and St Jude Medical LLC (0%).
Directors
According to the 2025 annual accounts
Bradley Jay Slater
Director
since 2022 · until 2029
Tim Demaerschalk
Director
since 2026 · until 2032
Shareholders
100%
St Jude Medical LLC
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 11 box F1
1930 Zaventem
Culliganlaan 2 box B
1831 Machelen (Brab.)
Active since 1 January 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →Abbott Belgian Pension Fund
Abbott Rapid Diagnostics
€ 7.9 million revenue · 2025
GARTNER BELGIUM
€ 54.2 million revenue · 2025
TMC Science & Technology
€ 41.8 million revenue · 2025
OPEN PIXEL SYSTEMS
€ 449,625 gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0441.665.942
- VAT number
- BE 0441.665.942
- Registered office
- Da Vincilaan 11 bus F1, 1930 Zaventem
- Names & denominations
- ABBOTT MEDICAL BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 1990
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten